In a retrospective cohort of CRC patients with resected brain metastases, up to 12% had IHC 3+ for ERBB2, which is higher than expected according to the reported prevalence of ERBB2-positive primaries [51]. The gene discussed is ERBB2; the disease is colorectal carcinoma.